array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(26) "Bio-RAD Laboratories, Inc."
["slug"]=>
string(33) "001cd-us-bio-rad-laboratories-inc"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/9d1c28c2-1b47-4093-8ed2-5151f3fe7920"
["description"]=>
string(867) "Since Bio-Rad was founded 70 years ago, we have continued to provide the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster, better results. Throughout our existence, we have built long-lasting customer relationships that help advance our research and development efforts in the introduction of new products and solutions. Today, Bio-Rad is a global leader, with a team of over 8,000 employees and a global network of operations that serves our life science research and clinical diagnostics customers, advancing science and saving lives, together.
#Biotechnology #Biotech #STEM #Research #Biology #Chemistry #Science #PeerReviewed #Diabetes #CancerResearch #HIVResearch #Laboratory #BioRad #Cancer #DiabetesResearch #AIDSResearch #ClinicalDiagnostics"
["address_street"]=>
string(20) "1000 Alfred Nobel Dr"
["address_place"]=>
string(8) "Hercules"
["address_region"]=>
string(10) "California"
["founding_date"]=>
string(10) "1952-02-08"
["website_domain"]=>
string(11) "bio-rad.com"
["website_url"]=>
string(23) "https://www.bio-rad.com"
["industry_codes"]=>
array(3) {
[0]=>
string(42) "In Vitro and In Vivo Diagnostic Substances"
[1]=>
string(33) "Laboratory Analytical Instruments"
[2]=>
string(47) "Electromedical and Electrotherapeutic Apparatus"
}
["employee_count"]=>
int(7900)
["article_count"]=>
int(661)
}
["articles"]=>
array(9) {
[0]=>
array(7) {
["title_en"]=>
string(46) "Bio-Rad Laboratories revenue growth flat in Q4"
["snippet_en"]=>
string(108) "Revenue increased almost 11% on a currency-neutral basis when COVID-related sales comparisons were excluded."
["url"]=>
string(105) "https://www.labpulse.com/business-insights/article/15307004/biorad-laboratories-revenue-growth-flat-in-q4"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/6c230f4e-7102-41dd-b3a2-306edd09bad9"
["source"]=>
string(12) "labpulse.com"
["publication_date"]=>
string(10) "2023-02-17"
["categories"]=>
array(3) {
[0]=>
string(8) "Epidemic"
[1]=>
string(24) "Quarterly/Annual Figures"
[2]=>
string(19) "New Revenue Streams"
}
}
[1]=>
array(7) {
["title_en"]=>
string(64) "Qiagen Sues Bio-Rad to Stave Off Patent Suit on DNA-Tagging Tech"
["snippet_en"]=>
string(254) "Qiagen NV filed a lawsuit Wednesday against Bio-Rad Laboratories Inc. seeking a federal court’ s judgment that Qiagen’ s QIAcuity system, which it says has been used in 48 states to test municipal wastewater for signs of Covid-19, doesn’ t infringe"
["url"]=>
string(101) "https://news.bloomberglaw.com/ip-law/qiagen-sues-bio-rad-to-stave-off-patent-suit-on-dna-tagging-tech"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/54380145-4298-49d2-9f3c-69c88b11fc5e"
["source"]=>
string(16) "bloomberglaw.com"
["publication_date"]=>
string(10) "2022-04-06"
["categories"]=>
array(7) {
[0]=>
string(27) "Business Model & Innovation"
[1]=>
string(10) "Litigation"
[2]=>
string(21) "Intellectual Property"
[3]=>
string(8) "Verdicts"
[4]=>
string(8) "Epidemic"
[5]=>
string(46) "Management of Legal and Regulatory Environment"
[6]=>
string(5) "Legal"
}
}
[2]=>
array(7) {
["title_en"]=>
string(115) "Eurofins Technologies Launches New Multiplex RT-PCR Respiratory Panel for SARS-CoV-2, Flu A, Flu B, RSV A and RSV B"
["snippet_en"]=>
string(150) "Regulatory News: Eurofins Technologies (Paris:ERF) announces the launch of two RT-PCR assays to accurately diagnose respiratory diseases caused by SAR"
["url"]=>
string(169) "https://www.businesswire.com/news/home/20211201005233/en/Eurofins-Technologies-Launches-New-Multiplex-RT-PCR-Respiratory-Panel-for-SARS-CoV-2-Flu-A-Flu-B-RSV-A-and-RSV-B"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/9d5af7d3-ed56-4c6a-b54d-8953ccf5e8e8"
["source"]=>
string(16) "businesswire.com"
["publication_date"]=>
string(10) "2021-12-01"
["categories"]=>
array(2) {
[0]=>
string(8) "Epidemic"
[1]=>
string(14) "Product Launch"
}
}
[3]=>
array(7) {
["title_en"]=>
string(149) "The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug"
["snippet_en"]=>
string(146) "ere's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 24)"
["url"]=>
string(204) "https://markets.businessinsider.com/news/stocks/the-daily-biotech-pulse-lilly-strikes-1-6b-r-d-collaboration-fsd-pulls-plug-on-covid-19-program-cassava-sinks-on-questions-about-alzheimer-s-drug-1030757345"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/221747b5-c266-4f66-a26f-aff81b2a3926"
["source"]=>
string(19) "businessinsider.com"
["publication_date"]=>
string(10) "2021-08-25"
["categories"]=>
array(2) {
[0]=>
string(8) "Epidemic"
[1]=>
string(24) "Quarterly/Annual Figures"
}
}
[4]=>
array(7) {
["title_en"]=>
string(162) "Anti-nuclear Antibody (ANA) Testing Market: COVID-19 Focused Report|Featuring Abbott Laboratories and Abcam Plc among others|Technavio | Virtual-Strategy Magazine"
["snippet_en"]=>
string(161) "Shape strategic responses through the phases of industry recovery Abbott Laboratories, Abcam Plc, and Bio-Rad Laboratories Inc. will emerge as major anti-nuclear"
["url"]=>
string(170) "https://virtual-strategy.com/2021/06/01/anti-nuclear-antibody-ana-testing-market-covid-19-focused-reportfeaturing-abbott-laboratories-and-abcam-plc-among-otherstechnavio/"
["image_url"]=>
NULL
["source"]=>
string(20) "virtual-strategy.com"
["publication_date"]=>
string(10) "2021-06-01"
["categories"]=>
array(2) {
[0]=>
string(8) "Epidemic"
[1]=>
string(6) "Merger"
}
}
[5]=>
array(7) {
["title_en"]=>
string(45) "FDA Grants EUA to Bio-Rad Reliance Assay Kits"
["snippet_en"]=>
string(76) "Help physicians more easily detect and differentiate SARS-CoV-2 in patients."
["url"]=>
string(111) "https://www.mpo-mag.com/content-microsite/mpo_covid-19/2021-02-16/fda-grants-eua-to-bio-rad-reliance-assay-kits"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/f7c5a6c8-094e-4883-8168-cf1ceaff0a6a"
["source"]=>
string(11) "mpo-mag.com"
["publication_date"]=>
string(10) "2021-02-16"
["categories"]=>
array(1) {
[0]=>
string(8) "Epidemic"
}
}
[6]=>
array(7) {
["title_en"]=>
string(52) "Hercules Company Scores Federal Coronavirus Contract"
["snippet_en"]=>
string(123) "Companies in Hercules and around the East Bay received millions from the government to help combat the coronavirus pandemic"
["url"]=>
string(97) "https://patch.com/california/pinole-hercules/hercules-company-scores-federal-coronavirus-contract"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/d9471cdf-805b-41d1-a195-344e7db39caa"
["source"]=>
string(9) "patch.com"
["publication_date"]=>
string(10) "2020-07-08"
["categories"]=>
array(3) {
[0]=>
string(8) "Epidemic"
[1]=>
string(22) "Purchasing contracting"
[2]=>
string(15) "Deals & Tenders"
}
}
[7]=>
array(7) {
["title_en"]=>
string(67) "FDA Lists Bio-Rad’s CFX96 Dx Real-Time PCR System for IVD Testing"
["snippet_en"]=>
string(32) "PCR Systems for COVID-19 Testing"
["url"]=>
string(105) "https://www.clinicallabmanager.com/fda-lists-bio-rads-cfx96-dx-real-time-pcr-system-for-ivd-testing-22748"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/76834d5e-9e30-4e75-9fb1-064590c885de"
["source"]=>
string(22) "clinicallabmanager.com"
["publication_date"]=>
string(10) "2020-05-19"
["categories"]=>
array(1) {
[0]=>
string(8) "Epidemic"
}
}
[8]=>
array(7) {
["title_en"]=>
string(58) "FDA Lists Bio-Rad’s Real-Time PCR System For IVD Testing"
["snippet_en"]=>
string(60) "The system may be used to help in the diagnosis of COVID-19."
["url"]=>
string(119) "https://www.mpo-mag.com/contents/view_breaking-news/2020-05-19/fda-lists-bio-rads-real-time-pcr-system-for-ivd-testing/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/16bd6634-eff3-43ea-9cd9-1a2b2abb39ed"
["source"]=>
string(11) "mpo-mag.com"
["publication_date"]=>
string(10) "2020-05-19"
["categories"]=>
array(2) {
[0]=>
string(8) "Epidemic"
[1]=>
string(5) "R & D"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(66)
}
[1]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(51)
}
[2]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(31)
}
[3]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(28)
}
[4]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(26)
}
[5]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(24)
}
[6]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(23)
}
[7]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(20)
}
[8]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(19)
}
[9]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(19)
}
[10]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(19)
}
[11]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(18)
}
[12]=>
array(2) {
["name"]=>
string(14) "Issuing Shares"
["count"]=>
int(14)
}
[13]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(14)
}
[14]=>
array(2) {
["name"]=>
string(18) "Ecological Impacts"
["count"]=>
int(13)
}
[15]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(13)
}
[16]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(9)
}
[17]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(9)
}
[18]=>
array(2) {
["name"]=>
string(10) "New Market"
["count"]=>
int(9)
}
[19]=>
array(2) {
["name"]=>
string(11) "Regulations"
["count"]=>
int(9)
}
[20]=>
array(2) {
["name"]=>
string(21) "Competitive Behaviour"
["count"]=>
int(8)
}
[21]=>
array(2) {
["name"]=>
string(11) "Competition"
["count"]=>
int(7)
}
[22]=>
array(2) {
["name"]=>
string(27) "Business Model & Innovation"
["count"]=>
int(7)
}
[23]=>
array(2) {
["name"]=>
string(46) "Management of Legal and Regulatory Environment"
["count"]=>
int(7)
}
[24]=>
array(2) {
["name"]=>
string(6) "Merger"
["count"]=>
int(7)
}
[25]=>
array(2) {
["name"]=>
string(16) "Case Settlements"
["count"]=>
int(6)
}
[26]=>
array(2) {
["name"]=>
string(13) "Credit Rating"
["count"]=>
int(5)
}
[27]=>
array(2) {
["name"]=>
string(15) "Business Ethics"
["count"]=>
int(5)
}
[28]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(5)
}
[29]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(5)
}
}
}
001cd-us-bio-rad-laboratories-inc
Bio-RAD Laboratories, Inc.
Location
California
Founded
1952-02-08
Website
https://www.bio-rad.com
Articles
661 Articles
Category
In Vitro and In Vivo Diagnostic Substances
Laboratory Analytical Instruments
Electromedical and Electrotherapeutic Apparatus
Description
Since Bio-Rad was founded 70 years ago, we have continued to provide the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster, better results. Throughout our existence, we have built long-lasting customer relationships that help advance our research and development efforts in the introduction of new products and solutions. Today, Bio-Rad is a global leader, with a team of over 8,000 employees and a global network of operations that serves our life science research and clinical diagnostics customers, advancing science and saving lives, together.
#Biotechnology #Biotech #STEM #Research #Biology #Chemistry #Science #PeerReviewed #Diabetes #CancerResearch #HIVResearch #Laboratory #BioRad #Cancer #DiabetesResearch #AIDSResearch #ClinicalDiagnostics
Qiagen NV filed a lawsuit Wednesday against Bio-Rad Laboratories Inc. seeking a federal court’ s judgment that Qiagen’ s QIAcuity system, which it says has been used in 48 states to test municipal wastewater for signs of Covid-19, doesn’ t infringe
Shape strategic responses through the phases of industry recovery Abbott Laboratories, Abcam Plc, and Bio-Rad Laboratories Inc. will emerge as major anti-nuclear
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
